Status:
UNKNOWN
Prophylactic Implantation of Biologic Mesh in Peritonitis
Lead Sponsor:
Azienda Ospedaliero-Universitaria di Parma
Conditions:
Incisional Hernia
Peritonitis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patients undergoing emergency surgery for peritonitis are at increased risk of abdominal wall-related complications. In patients with peritonitis the risk of incisional hernia (IH) is extremely elevat...
Eligibility Criteria
Inclusion
- Patients aged \> 18 years old
- Clinical and/or laboratory and/or radiological evidence/signs of peritonitis of any origin (peritoneal reactivity, positive Blumberg sign, fever, free air/fluid in abdominal cavity, leucocytosis, increased C-Reactive Protein (CRP), lactic dehydrogenase (LDH), tachycardia, tachypnea, clinical or radiological evidence/suspect of bowel ischemia)
- Eventual strong suspect of possible bacterial translocation (reduction of the natural intestinal barrier against bacterial translocation, i.e. bowel ischemia, bowel overdistension, intestinal occlusion, etc.)
- Surgical indication for midline laparotomy independently from eventual previous laparotomies
- Informed consent
Exclusion
- Patients aged \< 18 years old
- Informed consent refusal
- No Clinical and/or laboratory and/or radiological evidence/signs of peritonitis of any origin
- Surgical indication for laparotomies other than midline one
- Pregnancy.
Key Trial Info
Start Date :
December 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04681326
Start Date
December 1 2020
End Date
December 1 2023
Last Update
December 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Ospedaliera-Universitaria di Parma
Parma, Italy, 43125